Latest News on Gen-Probe Inc. (GPRO) Stock

  • The thorny problem of patentable eligible subject matter: an introduction [April 19 2014 03:29 AM]
  • The thorny problem of patentable eligible subject matter: an introduction   Lexology (registration) - 9 hours ago The Federal Circuit specifically mentioned these Guidelines in Enzo Biochem, Inc. v. Gen-Probe Inc. stating that “The PTO has issued Guidelines governing its internal practice for addressing that issue. Read more about this Gen-Probe Inc. (GPRO) news
  • Facility management: Leading through change [April 17 2014 02:33 PM]
  • Facility management: Leading through change   San Diego Source (subscription) - Apr 17, 2014 His facilities management and operations expertise was crafted at Gen-Probe Incorporated, Invitrogen Corporation and Pfizer Inc. prior to the formation of FM&O. Read more about this Gen-Probe Inc. (GPRO) news


  • DiagnoCure announces results of its Annual General and Special Meeting of ... [April 17 2014 02:11 PM]
  • DiagnoCure announces results of its Annual General and Special Meeting of ...   Virtual Press Office (press release) - Apr 17, 2014 The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe. now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer ... Read more about this Gen-Probe Inc. (GPRO) news


  • Hologic to Release Second Quarter Fiscal 2014 Operating Results on ... [April 9 2014 07:31 AM]
  • Hologic to Release Second Quarter Fiscal 2014 Operating Results on ...   The Wall Street Transcript - Apr 9, 2014 BEDFORD, Mass. , April 9, 2014 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis ... Read more about this Gen-Probe Inc. (GPRO) news

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center